BIOASSAY OF ANTIFUNGAL AGENT X-5079C IN SERUM OF PATIENTS
- 1 January 1961
- journal article
- research article
- Published by Elsevier
- Vol. 84 (4) , 534-+
- https://doi.org/10.1164/arrd.1961.84.4.534
Abstract
Bioassay of X-5079C by serum dilutions was unsuccessful because it requires large volumes of serum and because of the fungistatic action and decay of the antifungal agent in solution. By adaptation of the technique of placing impregnated discs on seeded agar, quantitative assays for the drug in serum are possible. The lower detectable limits of X-5079C are near 20 ug/ml of standard solution. This concentration is also detectable in serum. Serum concentrations above 11.0 ug/val have not been found in patients receiving the drug.Keywords
This publication has 5 references indexed in Scilit:
- ALTERED SULFOBROMOPHTHALEIN METABOLISM IN MAN INDUCED BY ANTIFUNGAL AGENT X-5079CPublished by Elsevier ,1961
- EFFECT OF ANTIFUNGAL AGENT X-5079C ON GROWTH OF HISTOPLASMA CAPSULATUM IN VITROPublished by Elsevier ,1961
- CHEMOTHERAPEUTIC ACTIVITY OF X-5079C IN SYSTEMIC MYCOSES OF MANPublished by Elsevier ,1961
- CHEMOTHERAPEUTIC STUDIES ON A NEW ANTIFUNGAL AGENT, X-5079C, EFFECTIVE AGAINST SYSTEMIC MYCOSESPublished by Elsevier ,1961
- CHEMOTHERAPEUTIC AND TOXIC ACTIVITY OF ANTIFUNGAL AGENT X-5079C IN EXPERIMENTAL MYCOSESPublished by Elsevier ,1961